Record / Open to challenge
Corrections
Figures on this site that you can tell me are wrong, where each one came from, and what happened when someone did.
Figures open to challenge
- Dialer call volume
-
Doximity Dialer carries more than 300,000 calls on an average workday.
- Whose figure
- Doximity’s figure
- Source
- Doximity Investor Relations, 5 February 2026 (opens in a new tab). For October–December 2025.
- Read again
- From 31 December 2026: a year after the quarter it describes.
- Also in
- Full sources
- The Doximity case study’s sources
- NextConsensus forecast FF-011
-
NextConsensus registered a 15% probability that the FDA approves Summit’s Biologics License Application (BLA) for ivonescimab by 14 November 2026, against a 70% estimate for similar FDA approvals by their deadline.
- Whose figure
- My estimate; the outcome has not been read
- Source
- The NextConsensus registry (opens in a new tab). Registered 26 September 2026; unresolved at the registry snapshot of 10 November 2026.
- Read again
- From 28 November 2026: the date its own rule reads the FDA record.
- Printed on
- Full sources
- The NextConsensus page
Challenges received
None yet. The first will be listed here with the date it arrived, what it said, and what I did about it.
What happens to a challenge
- You email me the figure and what is wrong with it. A source helps, and you do not need one.
- The challenge is listed on this page with the date it arrived, whether or not I end up agreeing. You are named only if you ask to be.
- If you are right, the figure changes on every page that prints it, each of those pages carries a dated note, and the old wording stays here, struck through, above what replaced it.
- If I think you are wrong, the entry says why, and what evidence would change my answer.
A figure that is not on this list can be challenged the same way. Tell me the page and the figure, and it joins the list with your challenge. Challenge another figure →
Revised